Figure 4From: A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndromeComparison of the CR rates of CAG regimen in AML patients according to karyotypes. Summary CR rates of CAG regimen were calculated using the random-effects model. Horizontal lines through the squares represent 95% CIs. The diamonds represent the overall CR event rate from the meta-analyses and the corresponding 95% CIs.Back to article page